Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julia Wong, MD
Dana-Farber Cancer Institute
Study Chair - Rinaa Punglia, MD MPH
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Vail Health
Edwards, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Johns Hopkins Medicine
Washington D.C., District of Columbia, United States
- Eastern Maine Medical Center
Brewer, Maine, United States
- Maine Medical Center
Scarborough, Maine, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital/north Shore Center for Outpatient Care
Danvers, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center (df/bwcc) at Milford Regional Medical Center
Milford, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center in Clinical Affiliation With South Shore Hospital
South Weymouth, Massachusetts, United States
- Lifespan/rhode Island Hospital
Providence, Rhode Island, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2018
- Primary completion
- 31 Oct 2023
- Completion
- 1 Apr 2030
- Last update posted
- 1 Nov 2024
- Registered enrollment
- 400
- Registry id
- NCT03422003
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.